Submit Your Feeds

Business News • PR NewsWire • Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success

Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success
Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success

ST. HELIER, Jersey, Nov. 15, 2014 /PRNewswire/ -- Novocure™, a commercial stage oncology company, announced today that Tumor Treating Fields (TTFields) delivered by the NovoTTF™-100A System in combination with standard-of-care temozolomide chemotherapy extended both...

View More : http://www.prnewswire.com/news-releases/novocure-announces-the-ef-14-phase-iii-clinical-trial-of-tumor-treating-fields-i...
Releted News by prnewswire
America's Beezie Madden Flew to Victory Tonight in the $50,000 Weston Canadian Open at the CSI4*-W Royal Horse Show, Toronto
MotoCMS 3.0 Will Soon Be Available for a Prelaunch at No Cost
Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success
Bowes Dermatology Offers Non-Invasive Neck Lift With The Revolutionary Velashape III
Moody Gardens Becomes Premiere Holiday Destination In Southwest With Debut Of ICE LAND: Ice Sculptures With SpongeBob SquarePants
Most Successful Condo Launch Since Recession Reflects Explosive Demand in Calgary - Analysts say Demand Outpacing Supply
Home Sitemap Contact Us
© businessNewsNewsNews.com